Funding news
Nutrivert logo

Nutrivert Raises $2.4M

Recently funded · $2.4M Series aHospitals and Health CareCAView source

Get the full Nutrivert company profile

Access contacts, investors, buying signals & more

Open in Dashboard

A biotechnology company aiming to curb the large-scale use of antibiotics in livestock production has secured fresh capital. Nutrivert, which is developing a novel non-antibiotic growth promotant, announced it has closed a $2.4M Series A funding round.

The investment will accelerate Nutrivert's mission to provide a safe and effective alternative to traditional antibiotics in animal agriculture. Its technology seeks to address growing concerns over antibiotic resistance by offering a sustainable solution for promoting animal growth without relying on conventional antimicrobial agents.

Other Canada companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
GGWP logo

GGWP

United States

$15.0M
2
LumiCup logo

LumiCup

United States

$4.4M
3
Star Catcher logo

Star Catcher

United States

$65.0M
4
Clarasight logo

Clarasight

United States

$11.5M
5
Judgment Labs logo

Judgment Labs

United States

$32.0M